Literature DB >> 8773913

Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.

S Basili1, D Ferro, R Leo, L Juliano, C Alessandri, C Cordova, F Violi.   

Abstract

BACKGROUND/AIMS: Bleeding time, a laboratory test which explores primary hemostasis, may be prolonged in cirrhosis, but whether abnormal bleeding time identifies patients with cirrhosis who are at risk of bleeding has never been investigated. The aim of this study was to analyze the relationship between bleeding time and the risk of gastrointestinal bleeding.
METHODS: Eighty consecutive patients with liver cirrhosis (47 males, 33 females; age, 60 +/- 9 years; range 31 to 83 years) and esophageal varices were enrolled in the study.
RESULTS: In the whole series of patients bleeding time was 11 +/- 6 min; it increased as the degree of liver deficiency increased, from low to severe (p = 0.007). During 14 +/- 9 (median (range): 12 (1-34) months of follow-up, 28 (35%) patients experienced gastrointestinal bleeding. They had a longer bleeding time, higher incidence of previous bleeding, more severe liver failure and larger variceal size than patients who did not bleed. However, multivariate analysis (Cox's model) showed that only previous bleeding, liver failure and variceal size were independently associated with bleeding. Similar data were obtained in patients with moderate-severe liver insufficiency (B and C degree according to Child-Pugh's classification). In patients who had never bled (n = 54), the severity of liver failure and variceal size were independent predictors of bleeding.
CONCLUSIONS: This study shows that bleeding time is not a predictor of gastrointestinal bleeding in patients with cirrhosis.

Entities:  

Mesh:

Year:  1996        PMID: 8773913     DOI: 10.1016/s0168-8278(96)80143-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  New concepts of coagulation and bleeding in liver disease.

Authors:  Patrick G Northup; Stephen H Caldwell
Journal:  Intern Emerg Med       Date:  2010-02       Impact factor: 3.397

2.  Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series.

Authors:  B Linnane; M R Oliver; P J Robinson
Journal:  Arch Dis Child       Date:  2006-05-31       Impact factor: 3.791

3.  Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.

Authors:  S Basili; V Raparelli; L Napoleone; G Talerico; G R Corazza; F Perticone; D Sacerdoti; A Andriulli; A Licata; A Pietrangelo; A Picardi; G Raimondo; F Violi
Journal:  Am J Gastroenterol       Date:  2017-12-19       Impact factor: 10.864

Review 4.  Changing Concepts of Cirrhotic Coagulopathy.

Authors:  Armando Tripodi; Massimo Primignani; Pier M Mannucci; Stephen H Caldwell
Journal:  Am J Gastroenterol       Date:  2016-11-01       Impact factor: 10.864

Review 5.  Platelets in liver and renal disease.

Authors:  Michele P Lambert
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.